Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia

Table 1 Baseline characteristics of groups A and B (mean ± SD)

	Group A (n = 66)	Group B (n = 68)	P vaule
Age (yr)	45.00 ± 10.91	44.03 ± 11.30	0.74
Sex ratio (male/female)	47/19	50/18	0.76
Body height (cm)	169.07 ± 7.96	169.71 ± 7.89	0.88
Weight (kg)	75.71 ± 10.99	75.16 ± 11.33	0.93
BMI (kg/m2)	26.37 ± 3.12	25.96 ± 2.70	0.57
HR (/min)	75.57 ± 6.24	75.89 ± 6.58	0.32
Duration of NAFLD (mo)	22.32 ± 38.82	13.65 ± 20.00	0.55
SBP (mmHg)	126.59 ± 10.97	125.89 ± 9.87	0.58
DBP (mmHg)	82.26 ± 7.50	81.59 ± 8.02	0.81
HB (g/L)	143.31 ± 16.49	145.53 ± 15.52	0.58
RBC (× 1012/L)	4.71 ± 0.57	4.76 ± 0.61	0.84
WBC (× 109/L)	6.16 ± 1.58	6.52 ± 1.45	0.18
Platelet (× 109/L)	205.79 ± 49.43	195.78 ± 53.33	0.53
BUN (mmol/L)	5.30 ± 1.67	5.19 ± 1.57	0.63
Creatinine (μmol/L)	72.56 ± 15.27	76.69 ± 15.35	0.2
FBG (mmol/L)	5.89 ± 1.20	5.46 ± 1.82	0.43
Total symptom scores	1.87 ± 1.18	1.79 ± 0.45	0.23
Steatosis degree 0/1/2/3 (%)	0/30/56/14	0/37/48/15	0.63

BMI: Body mass index; HR: Heart rate; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; HB: Haematoglobin; RBC: Red blood cells; WBC: White blood cells; BUN: Blood urea nitrogen; FBG: Fasting blood glucose.